AMG 162
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMG 162, covering 2010-01-26 to 2014-06-03. Get the full timeline:
Most recent: Clinical Trial Update: AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer [Phase 3]